Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype

Products

ColdZyme® Protects Against Viruses In The Upper Respiratory Tract That Cause Cold And Flu-Like Symptoms

Use ColdZyme® at the first signs of experiencing cold and flu-like symptoms. ColdZyme® can also be used when in areas where you can be exposed to viruses.

How ColdZyme® Works

At the first signs of experiencing cold and flu-like symptoms, spray ColdZyme into the back of the throat where ColdZyme® creates a barrier that captures the viruses that is causing the symptoms and subsequently inhibits their ability to infect other cells and replicate.

Benefits of Using ColdZyme®

  • Shortens the duration of common cold/upper respiratory tract infection/flu-like symptoms if used at an early stage of the infection.
  • Alleviates common cold/upper respiratory tract infection/flu-like symptoms, including sore throat.
  • Protects in areas of potential exposure to viruses causing common cold/upper respiratory tract infection/flu-like symptoms.

For those that cannot afford to be sick

ColdZyme® has a unique defensive action that puts people in control of their upper respiratory health. This is especially important for those that cannot afford to be sick. From doctors and emergency service personnel to athletes in training and the immuno-compromised - ColdZyme can help defend against cold & flu viruses.

ColdZyme® mouth spray is suitable for adults and children over 4 years of age.

ColdZyme is a CE-marked medical device (MDR Class III).

Scientifically proven

The efficacy and action of ColdZyme has been proven through a number of different scientific studies and clinical investigations.

Read more about the included studies here.

Socioeconomic benefits

The potential socioeconomic effect of ColdZyme on the Swedish population suggests the reduction in illness would contribute to an overall health economic gain.

A reduction of just one day of illness would result in an annual SEK 1.4 billion boost for society. This is based on 10 percent of the 4.7 million full-time employed adults in Sweden.1

1Studie av den samhällsekonomiska effekten för den svenska befolkningen vid användning av ColdZyme Munspray, Nordic Evaluation Group AB (Nordeg) på uppdrag av Enzymatica 2013

More about Coldzyme®

For more information please visit the product website:

ColdZyme

We use cookies and similar technologies on our website to allow us to promote our services and enhance your browsing experience.

In order for the website to function properly we always use strictly necessary cookies, however, in order to provide you with the optimal experience and functions of this website we need your consent for our functional, performance and advertising cookies.

We also use third party cookies to improve our site through web analysis. For these purposes we share your data with third parties.

Read more about cookies here

My choices

These cookies are essential for the site to work and provide you with a better user experience.

From the data that we collect via Google Analytics, we can see and analyse the use of the site over time, and produce aggregated and anonymised statistics in order to develop the site and to continue to offer you the best possible experience.

To understand how we use cookies, or for information on how to withdraw or change your cookie settings, please see our Cookie Policy.